Publication | Open Access
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
167
Citations
1
References
2021
Year
VaccinationVaccine SafetyVaccinologyPreventive MedicineVaccine DevelopmentVaccine SurveillanceFebruary 2021Emergency Use AuthorizationJanssen Covid-19Vaccine EfficacyAdvisory CommitteeInfection ControlPublic HealthDrug AdministrationMedicineVaccine HesitancyCovid-19
the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Janssen COVID-19 (Ad.26.COV2.S) vaccine (Janssen Biotech, Inc, a Janssen Pharmaceutical company, Johnson & Johnson; New
| Year | Citations | |
|---|---|---|
Page 1
Page 1